Veröffentlichungen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Beule, Dieter Dr. (1) Birchmeier-Kohler, Carmen Prof. Dr. (1) Blankenstein, Thomas Prof. Dr. (2) Blüthgen, Nils (1) Bunse, Mario Dr. (2) Daniel, Peter Prof. Dr. (1) Daumke, Oliver Prof. Dr. (1) Kammertöns, Thomas Dr. (2) Kärgel, Eva Dr. (1) Leisegang, Matthias Dr. (1) Mathas, Stephan Dr. (8) Pezzutto, Antonio Prof. Dr. (1) Rhein, Simone Dr. (1) Rocks, Oliver Dr. (1) Selbach, Matthias Prof. Dr. (7) Uckert, Wolfgang Prof. Dr. (12) Wolf, Jana Prof. Dr. (1) Wollert-Wulf, Brigitte (4) (-) Chen, Wei Prof. Dr. (1) (-) Janz, Martin Dr. (8) (-) Lusatis, Simone (1) (-) Scheidereit, Claus Prof. Dr. (1) (-) Biologie maligner Lymphome (8) Genetik und Genomik von Herz- Kreislauferkrankungen (3) Genetik und Pathophysiologie des Herz - Kreislaufsystems (1) Hypertonie-vermittelter Endorganschaden (1) Hypertonie bedingte Endorganschäden (1) Micro-RNS und molekulare Mechanismen von Stoffwechselerkrankungen (1) Molekulare und Zelluläre Grundlagen der Embryonalentwicklung (1) (-) Molekulare Zellbiologie und Gentherapie (1) (-) Proteom Dynamik (1) RNA Biologie und Posttranscriptionale Regulation (1) Signaltransduktion in Tumorzellen (9) Systembiologie von Gen-regulatorischen Elementen (1) 1999 (1) 2001 (1) 2002 (3) 2003 (3) 2004 (2) 2005 (2) (-) 2006 (4) (-) 2007 (2) 2008 (2) 2009 (3) 2010 (1) 2011 (5) 2012 (2) (-) 2013 (3) 2014 (2) 2015 (3) 2016 (4) 2017 (3) 2018 (1) 2019 (2) 2020 (4) 2021 (5) 2022 (1) 9 Ergebnisse: Active Filter: Chen, Wei Prof. Dr.Janz, Martin Dr.Lusatis, SimoneScheidereit, Claus Prof. Dr.Biologie maligner LymphomeMolekulare Zellbiologie und GentherapieProteom Dynamik200620072013 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 26. September 2013 in Blood IκB-ζ controls the constitutive NF-κB target gene network and survival of ABC DLBCL H. Nogai S.S. Wenzel S. Hailfinger M. Grau E. Kaergel V. Seitz B. Wollert-Wulf M. Pfeifer A. Wolf M. Frick K. Dietze H. Madle A. Tzankov M. Hummel B. Dörken C. Scheidereit M. Janz P. Lenz M. Thome G. Lenz 23. Juli 2013 in Proc Natl Acad Sci U S A PTEN loss defines a PI3K/AKT pathway-dependent germinal center subtype of diffuse large B-cell lymphoma M. Pfeifer M. Grau D. Lenze S.S. Wenzel A. Wolf B. Wollert-Wulf K. Dietze H. Nogai B. Storek H. Madle B. Dörken M. Janz S. Dirnhofer P. Lenz M. Hummel A. Tzankov G. Lenz 01. Mai 2013 in Mol Cell Proteomics Argonaute2 regulates the pancreatic β-cell secretome S.G. Tattikota M.D. Sury T. Rathjen H.H. Wessels A.K. Pandey X. You C. Becker W. Chen M. Selbach M.N. Poy 01. Mai 2007 in Br J Haematol Loss of bHLH transcription factor E2A activity in primary effusion lymphoma confers resistance to apoptosis A. Lietz M. Janz M. Sigvardsson F. Jundt B. Doerken S. Mathas 01. April 2007 in Leukemia Pharmacologic activation of p53-dependent and p53-independent apoptotic pathways in Hodgkin/Reed-Sternberg cells M. Janz T. Stuehmer L.T. Vassilev R.C. Bargou 15. Mai 2006 in Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas 01. April 2006 in Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel 15. März 2006 in Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou 01. Februar 2006 in Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken
26. September 2013 in Blood IκB-ζ controls the constitutive NF-κB target gene network and survival of ABC DLBCL H. Nogai S.S. Wenzel S. Hailfinger M. Grau E. Kaergel V. Seitz B. Wollert-Wulf M. Pfeifer A. Wolf M. Frick K. Dietze H. Madle A. Tzankov M. Hummel B. Dörken C. Scheidereit M. Janz P. Lenz M. Thome G. Lenz
23. Juli 2013 in Proc Natl Acad Sci U S A PTEN loss defines a PI3K/AKT pathway-dependent germinal center subtype of diffuse large B-cell lymphoma M. Pfeifer M. Grau D. Lenze S.S. Wenzel A. Wolf B. Wollert-Wulf K. Dietze H. Nogai B. Storek H. Madle B. Dörken M. Janz S. Dirnhofer P. Lenz M. Hummel A. Tzankov G. Lenz
01. Mai 2013 in Mol Cell Proteomics Argonaute2 regulates the pancreatic β-cell secretome S.G. Tattikota M.D. Sury T. Rathjen H.H. Wessels A.K. Pandey X. You C. Becker W. Chen M. Selbach M.N. Poy
01. Mai 2007 in Br J Haematol Loss of bHLH transcription factor E2A activity in primary effusion lymphoma confers resistance to apoptosis A. Lietz M. Janz M. Sigvardsson F. Jundt B. Doerken S. Mathas
01. April 2007 in Leukemia Pharmacologic activation of p53-dependent and p53-independent apoptotic pathways in Hodgkin/Reed-Sternberg cells M. Janz T. Stuehmer L.T. Vassilev R.C. Bargou
15. Mai 2006 in Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas
01. April 2006 in Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel
15. März 2006 in Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou
01. Februar 2006 in Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken
